Clinical Trial Update: Effect of Saccharomyces Boulardii CNCM I-745 (Sb) on Bloody Diarrhea in Children. A Double Blind, Randomized, Controlled Study ( Sb192-SUH ) [Phase 4]

View source ↗

Summary

Phase 4 study evaluating Saccharomyces boulardii CNCM I-745 for acute bloody diarrhea in children, in a double-blind randomized setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bloody Diarrhea in Children

Drugs mentioned

• Saccharomyces boulardii CNCM I-745 (Saccharomyces boulardii)

Snippet

Sponsor: Fundación Hospital de Pediatría Prof. Dr. Juan P. Garrahan | Conditions: Acute Bloody Diarrhea of 7 Days or Less Duration | Phase 4 | Status: ACTIVE_NOT_RECRUITING